These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 32124558

  • 1. Plasma-based microRNA signatures in early diagnosis of breast cancer.
    Li X, Zou W, Wang Y, Liao Z, Li L, Zhai Y, Zhang L, Gu S, Zhao X.
    Mol Genet Genomic Med; 2020 May; 8(5):e1092. PubMed ID: 32124558
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A five-miRNA panel in plasma was identified for breast cancer diagnosis.
    Li M, Zou X, Xia T, Wang T, Liu P, Zhou X, Wang S, Zhu W.
    Cancer Med; 2019 Nov; 8(16):7006-7017. PubMed ID: 31568692
    [Abstract] [Full Text] [Related]

  • 6. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
    Jusoh AR, Mohan SV, Lu Ping T, Tengku Din TADAAB, Haron J, Romli RC, Jaafar H, Nafi SN, Tuan Salwani TI, Yahya MM.
    Asian Pac J Cancer Prev; 2021 May 01; 22(5):1375-1381. PubMed ID: 34048164
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of Serum MicroRNAs (miR-9-5p, miR-17-5p, and miR-148a-3p) as Potential Biomarkers of Breast Cancer.
    Li X, Tang X, Li K, Lu L.
    Biomed Res Int; 2022 May 01; 2022():9961412. PubMed ID: 35111850
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
    Kumar S, Sharawat SK, Ali A, Gaur V, Malik PS, Kumar S, Mohan A, Guleria R.
    Curr Probl Cancer; 2020 Aug 01; 44(4):100540. PubMed ID: 32007320
    [Abstract] [Full Text] [Related]

  • 11. Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
    Garrido-Cano I, Constâncio V, Adam-Artigues A, Lameirinhas A, Simón S, Ortega B, Martínez MT, Hernando C, Bermejo B, Lluch A, Lopes P, Henrique R, Jerónimo C, Cejalvo JM, Eroles P.
    Int J Mol Sci; 2020 Oct 08; 21(19):. PubMed ID: 33050096
    [Abstract] [Full Text] [Related]

  • 12. Assessment of circulating microRNA specific for patients with familial adenomatous polyposis.
    Yamano T, Kubo S, Sonoda E, Kominato T, Kimura K, Yasuhara M, Kataoka K, Son J, Babaya A, Takenaka Y, Matsubara T, Beppu N, Ikeda M.
    PLoS One; 2021 Oct 08; 16(5):e0250072. PubMed ID: 33945535
    [Abstract] [Full Text] [Related]

  • 13. Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy.
    Di Cosimo S, Appierto V, Pizzamiglio S, Silvestri M, Baselga J, Piccart M, Huober J, Izquierdo M, de la Pena L, Hilbers FS, de Azambuja E, Untch M, Pusztai L, Pritchard K, Nuciforo P, Vincent-Salomon A, Symmans F, Apolone G, de Braud FG, Iorio MV, Verderio P, Daidone MG.
    Int J Mol Sci; 2020 Feb 18; 21(4):. PubMed ID: 32085669
    [Abstract] [Full Text] [Related]

  • 14. Aberrant expression of a five-microRNA signature in breast carcinoma as a promising biomarker for diagnosis.
    Bitaraf A, Babashah S, Garshasbi M.
    J Clin Lab Anal; 2020 Feb 18; 34(2):e23063. PubMed ID: 31595567
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis.
    Zou X, Xia T, Li M, Wang T, Liu P, Zhou X, Huang Z, Zhu W.
    Cancer Biomark; 2021 Feb 18; 30(1):41-53. PubMed ID: 32894240
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohort.
    Chiorino G, Petracci E, Sehovic E, Gregnanin I, Camussi E, Mello-Grand M, Ostano P, Riggi E, Vergini V, Russo A, Berrino E, Ortale A, Garena F, Venesio T, Gallo F, Favettini E, Frigerio A, Matullo G, Segnan N, Giordano L.
    Sci Rep; 2023 Jul 25; 13(1):12040. PubMed ID: 37491482
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.